Thursday, 06 November 2014
  0 Replies
  4.9K Visits
This summary has been extracted from the IVAC website. For best viewing, please click here. For the first time in its history, the International Symposium on Pneumococci and Pneumococcal Disease (ISPPD), was held in Asia in March 2014. Nearly 1,000 scientists and public health experts from around the world convened from March 9 to 13 in Hyderabad, India to discuss the latest developments in pneumococcal research and pneumococcal disease prevention. Given the high burden of pneumococcal disease in India and South Asia, and the need for action for prevention and control, IVAC and INCLEN Trust hosted a pre-ISPPD symposium titled “Pneumococcal Disease in South Asia: The Promise of Vaccines.” The meeting objectives included: Review available data on pneumococcal disease burden in South Asia Review the status of pneumococcal conjugate vaccine (PCV) introduction and impact in South Asia Share experiences of vaccine introduction and impact Discuss challenges, strategies, and experiences related to vaccine introduction and impact measurement Some of the presentations are listed below. For the entire list, please visit: 1. Thomas Cherian, World Health Organization (WHO): The Epidemiology and Burden of Pneumococcal Disease 2. Rajesh Kumar, PGIMER School of Public Health (India): Pneumococcal Vaccines Safety & Efficacy 3. Asad Ali, Aga Khan University (Pakistan): Pneumococcal Conjugate Vaccine (PCV) Impact in Pakistan 4. Eric Tayag, Philippines Department of Health: Philippines: Pneumococcal Conjugate Vaccine (PCV) Introduction and Experience 5. Cynthia Whitney, Centers for Disease Control and Prevention (USA): Indirect Effects - Multiplying the Benefits of Vaccinating Children 6. Anonh Xeuatvongsa, Director, National Immunization Program, Ministry of Health (Lao PDR): Introduction and Impact of PCV13 on Carriage and Pneumonia in Lao PDR 7. Shrijana Shrestha, Dean of School of Medicine, Patan Academy of Health Sciences (Nepal): Pneumococcal Vaccine in Nepal - Nine Years of Planning
There are no replies made for this post yet.